Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine

• Main Authors: Paola Marchisio, Susanna Esposito, Gian Carlo Schito, Anna Marchese, Roberta Cavagna, Nicola Principi
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2002-05-01
• Series: Emerging Infectious Diseases
• Subjects: children; conjugate vaccine; epidemiology; Italy; nasopharyngeal carriage; Streptococcus pneumoniae
• Online Access: https://wwwnc.cdc.gov/eid/article/8/5/01-0235_article
• ISSN: 1080-6040; 1080-6059

We assessed the prevalence of Streptococcus pneumoniae serotypes in the nasopharynx of healthy children, antimicrobial susceptibility patterns, risk factors for carriage, and the coverage of heptavalent pneumococcal conjugate vaccine. In 2,799 healthy infants and children, the S. pneumoniae carrier rate was 8.6% (serotypes 3, 19F, 23F, 19A, 6B, and 14 were most common). Most pneumococci (69.4%) were resistant to one or more antimicrobial classes. The rate of penicillin resistance was low (9.1%); macrolide resistance was high (52.1%). Overall, 63.2% of the isolates belonged to strains covered by the heptavalent pneumococcal vaccine. This percentage was higher in children <2 years old (73.1%) and in those >2-5 years old(68.9%). Sinusitis in the previous 3 months was the only risk factor for carrier status; acute otitis media was the only risk factor for the carriage of penicillin-resistant S. pneumoniae. Most the isolated strains are covered by the heptavalent conjugate vaccine, especially in the first years of life, suggesting that its use could reduce the incidence of pneumococcal disease.